Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
sdAb 3F11
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/10/2020
sdAb 4D8
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/10/2020
sdAb 2F2
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/10/2020
LCB3
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/09/2020
LCB1
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/09/2020
Triazavirin
Potential treatment - clinical evidence Experimental Antiviral Sep/08/2020
Ferroquine
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/08/2020
LFG316
Potential treatment - clinical evidence Experimental Other treatment Sep/08/2020
NA7
Potential treatment - theoretical effect Experimental Antiviral Sep/08/2020
3-{[(1R)-1-Benzyl-2-sulfanylethyl]amino}-3-oxopropanoic acid
Potential treatment - theoretical effect Experimental Antiviral Sep/08/2020
Azane;bis[[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate
Potential treatment - theoretical effect Experimental Antiviral Sep/08/2020
Diadenosine hexaphosphate
Potential treatment - theoretical effect Experimental Antiviral Sep/08/2020
Alarelin
Potential treatment - theoretical effect Experimental Antiviral Sep/07/2020
Thymopentin
Potential treatment - theoretical effect Experimental Antiviral Sep/07/2020
rAd5-S
Potential treatment - clinical evidence Experimental Vaccine Sep/04/2020
rAd26-S
Potential treatment - clinical evidence Experimental Vaccine Sep/04/2020
[((5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE)]
Potential treatment - theoretical effect Experimental Antiviral Sep/02/2020
P2,P3 Ketoamide derivative
Potential treatment - theoretical effect Experimental Antiviral Sep/02/2020
LMG_1552174
Potential treatment - theoretical effect Experimental Antiviral Aug/28/2020
SYN_15517940
Potential treatment - theoretical effect Experimental Antiviral Aug/28/2020